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The combination of superior mesenteric artery (SMA) pseudoaneurysm and arteriovenous (AV) fistula is a rare
complication following penetrating abdominal trauma. We report a case of a post-traumatic SMA pseudoaneurysm and
large fistula between the SMA and superior mesenteric vein (SMV), which was successfully treated with an endovascular
stent graft. ( J Vasc Surg 2008;48:730-34.)CASE REPORT
A 39-year-old female had sustained an abdominal gunshot
wound 20 years earlier. She recovered from her injuries and
remained asymptomatic until the past year when she developed
progressive abdominal pain. Physical examination revealed tender-
ness to palpation, fullness in the upper abdomen, and a loud
continuous bruit. Computed tomography (CT) scan of the abdo-
men demonstrated a pseudoaneurysm arising from the SMA and a
large AV fistula between the SMA and SMV, with marked dilata-
tion of the SMV and portal veins (Fig 1). On the basis of the
localized nature of the pain on clinical examination, the patient’s
symptoms were thought to be due to mass effect of the pseudoan-
eurysm, with possibly some component from hepatic venous con-
gestion. There was no evidence of high output cardiac failure or
gastrointestinal bleeding or other clinical manifestations of portal
venous hypertension.
In light of the history of prior abdominal injury and operation,
and the findings that suggested mesenteric venous hypertension,
she was judged to be at risk of bleeding complications with direct
surgical repair. She was referred for angiography and possible
transcatheter intervention. Abdominal aortography was performed
in the anterior-posterior and lateral projections with the use of a 5F
pigtail catheter (Fig 2). A 5F Simmons-1 catheter (Cordis, Miami
Lakes, Fla) was then used to engage the SMA, and selective
angiography was performed. High flow into the AV fistula limited
visualization of the SMA branch vessels. An angled glide catheter
(Terumo, Ann Arbor, Mich) was advanced over a guidewire more
distally in the SMA; however, visualization remained poor. A 7F
Ansel sheath (Cook Medical, Bloomington, Ind) was then ad-
vanced into the SMA over the guidewire. Intravenous heparin was
administered to maintain an activated clotting time 250 seconds.
A 6-mm diameter by 2-cm long Powerflex Plus angioplasty balloon
(Cordis, Miami Lakes, Fla) was advanced into the SMA, and
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730balloon occlusion angiography of the SMA was then performed.
The SMA pseudoaneurysm and fistula, as well as the SMA branch
vessels, were then well visualized (Fig 2), which allowed a better
determination as to whether a covered stent could be safely de-
ployed without occluding important branch vessels. A 7-mm di-
ameter by 16-mm long iCAST covered-stent (Atrium Medical,
Hudson, NH) was then deployed over the origin of the AV fistula
and pseudoaneurysm. Subsequent angiography demonstrated in-
complete sealing of the pseudoaneurysm and AV fistula. A second
7-mm diameter by 22-mm long iCAST stent was deployed more
proximally, overlapping the first device. Subsequent angiography
demonstrated complete exclusion of the pseudoaneurysm and AV
fistula. Post-dilatation of the proximal stent graft with an 8-mm
diameter by 2-cm long Powerflex Plus balloon (Cordis, Miami
Lakes, Fla) was performed. Subsequent angiography demonstrated
an excellent angiographic result with complete exclusion of the
pseudoaneurysm and AV fistula, and preservation of important
SMA branches (Fig 3).
The procedure was well tolerated and there were no subse-
quent complications. The patient’s symptoms of abdominal dis-
comfort resolved after the procedure, as did the abdominal bruit.
She was maintained on aspirin and clopidogrel for 6 months to
prevent subacute stent thrombosis. Because of the grossly dis-
tended SMV and a concern for the potential of SMV thrombosis
after closure of the AV fistula, she was also anticoagulated with
warfarin for 6 months. There were no bleeding complications.
After 6 months, she was continued on aspirin only. She remained
asymptomatic at 6-month follow-up. A repeat CT angiogram at
that time showed no SMA pseudoaneurysm or AV fistula and
resolution of the previously noted portal venous distension (Fig 4).
DISCUSSION
Abdominal visceral aneurysms and pseudoaneurysm are
associated with a significant risk of rupture and death.1,2 In
a case series from the Cleveland Clinic of 90 patients, 8
presented with ruptures.2 Of the 48 patients treated percu-
taneously, the 30-day mortality was 8.3%. The natural
history of SMA aneurysms and pseudoaneurysm is not
well described in the literature. The largest case series is
reported from the Mayo Clinic in which 21 patients with
SMA aneurysms were identified.3 In this series, eight
super
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ative mortality for repair was 37.5%. Patients who under-
went elective repair had no associated mortality. The
authors therefore concluded that SMA aneurysms pose
an important risk of rupture and should be treated if the
operative risk is low.
Endovascular treatment of SMA aneurysm or
pseudoaneurysm. Most reports have focused on the use
Fig 1. Pretreatment computed tomography scan of abdo
(arrow). B, Shows the distended superior mesenteric vein,
Fig 2. Pretreatment angiography. A, Shows the superio
arteriovenous fistula. B, Shows the SMA pseudoaneu
improved visualization of the branches of the SMA.of coils to embolize SMA aneurysms and pseudoaneu-rysms.4-7 Other embolic agents have been used, including
cyanoacrylate and thrombin.2,7,8 A few case reports and
case series also describe the use of stents and stent grafts to
exclude these lesions.7,9-12 In general, these reports (which
comprise small numbers of patients) show durable results
with duration of follow-up from 3 months to 5 years.9-12
One case report described an endoleak at the distal edge of
a covered stent at 3 months,13 which was subsequently
A, Shows early contrast in a dilated portal venous system
ior mesenteric artery, and pseudoaneurysm (arrows).
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tulae are uncommon and exist in the published literature
primarily as case reports and case series. Occurrence of
Fig 3. Posttreatment angiography. A, Shows the overla
B and C, Show different views of the SMA with comple
Fig 4. Posttreatment computed tomography scan of ab
superior mesenteric artery (SMA). B, Shows the SMA, th
the superior mesenteric vein.SMA-SMV fistulae are exceedingly rare and have beenprimarily associated with traumatic injuries, including gun-
shot wounds or abdominal surgery.14-16 Delayed presenta-
tion of SMA-SMVAV fistulae can occur up to 10 years after
iCAST stents in the superior mesenteric artery (SMA).
clusion of the fistula and pseudoaneurysm.
n.A, Three-dimensional reconstruction of the aorta and
bosed pseudoaneurysm, and absence of early contrast inppingdome
roman initial injury.14,17 Clinically, these fistulae can cause
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dominal pain and symptoms of portal hypertension includ-
ing variceal bleeding.14,16,18-21 If the systemic-portal fistula
is recognized early, treatment may result in reversal of the
portal hypertension. In addition, aneurysmal dilatation of
the SMV as a result of the fistula may predispose to throm-
botic portal venous obstruction.21
The treatment of visceral AV fistulae, in particular
SMA-SMV fistulae, may be surgical14,15 or endovascular.
Endovascular repair has involved the use of embolization
coils and covered stents.18,19,22 To the best of our knowl-
edge, our case is the second report describing the use of a
covered stent to treat an SMA-SMV AV fistula.22 In the
case of coil embolization, important considerations include
the risk of distal embolization into the portal vein, which
may lead to portal vein thrombosis.18,20 The coils may also
embolize into the distal SMA or back into the aorta,
potentially resulting in bowel infarction or lower extremity
ischemia.
There are limited data on the combination of SMA
pseudoaneurysm and AV fistula. In a case similar to the one
presented, Rosenthal et al16 described a combination of
aorto-superior mesenteric bypass and postoperative percu-
taneous transcatheter embolization to treat a patient with a
traumatic SMA-SMV fistula and an SMA pseudoaneurysm.
Technical aspects: stent graft. High flow in the AV
fistula as well as close proximity of the artery and vein made
successful coil embolization unlikely. This case report illus-
trates the treatment of a visceral AV fistula and pseudoan-
eurysm using stent grafts, the objective of which is to close
the AV fistula and seal the pseudoaneurysm without oc-
cluding flow into the side branches. Balloon-expandable
covered stents (eg, iCAST) provide significant advantages
over a self-expanding stent graft by allowing more precise
deployment, which is of particular importance in avoiding
the mesenteric branch vessels. Furthermore the iCAST
covered stent comes in diameters of 5 to 10 mm, can be
delivered through a 6F or 7F sheath, and has a wide
expansion range, allowing for further expansion of the stent
if the initial deployment was undersized. On the other
hand, self-expanding covered stents have a relatively limited
range of expandability. In this case report, the first covered
stent did not adequately seal the AV fistula and pseudoan-
eurysm. One possible explanation is that the iCAST cov-
ered stent shortens slightly when expanded, possibly result-
ing in an uncovered communication from the SMA and
pseudoaneurysm proximally. A second stent graft was
placed more proximally, resulting in complete sealing. Of
note, the placement of any balloon-expandable stent across
sharp bends (which may be seen in the proximal SMA) may
potentially result in abnormal vessel straightening, vessel
injury, or stent deformation. In this particular case, the area
of interest in the SMA was distal to the sharp bend and was
in a straight segment, allowing for safe deployment of the
stent.
There are important caveats for the use of covered
stents. Good expansion of the stent graft and good appo-sition of the stent to the vessel wall are critical to minimize
the risk of subacute or late stent thrombosis, which can
potentially lead to acute organ ischemia and infarction.
Therefore, dual antiplatelet therapy with aspirin and
a thienopyridine are empirically recommended in the
postimplantation period with subsequent life-long treat-
ment with aspirin. The role and optimal duration of dual
antiplatelet therapy remain unclear. Finally, long-term re-
sults of stent grafts in this setting remain unknown, with
stent thrombosis leading to acute mesenteric ischemia be-
ing an important concern.
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